Multiallergen-specific immunotherapy in polysensitized patients: where are we? - Wikidata - wikimedia - TriplyDB

Multiallergen-specific immunotherapy in polysensitized patients: where are we?

Multiallergen-specific immunotherapy in polysensitized patients: where are we?

http://www.wikidata.org/entity/Q39466603

about

Management of the polyallergic patient with allergy immunotherapy: a practice-based approach Sublingual immunotherapy in allergic rhinitis: efficacy, safety, adherence and guidelines Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease Allergic respiratory disease (ARD), setting forth the basics: proposals of an expert consensus report.Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: an Allergists' Consensus.Arguing the misconceptions in allergen-specific immunotherapy.Sublingual immunotherapy for allergic rhinitis: where are we now?Long-term Effects of Specific Allergen Immunotherapy Against House Dust Mites in Polysensitized Patients With Allergic Rhinitis.Correlation between the number of allergen sensitizations and immunoglobulin E: monosensitization vs polysensitization.

P2860

Q26772200-7779E822-5364-4B24-8D8B-C35A0098EEB4 Q27002341-F4CB8CF6-764B-4BF8-8545-3CD48BB0D4DD Q33592972-9E1A68F4-C395-44AC-AE72-514DB9F1D495 Q33706588-5EDA3BB7-6B16-409B-8556-9113D6F836E9 Q35101859-32B4C654-13CA-45CD-8601-5E899F32CA9A Q38217592-952FF24D-DD16-4B7B-8CF1-2EFF4FE003C6 Q38617692-8FB81416-2C4D-43AA-B673-7FF069F042F5 Q40233194-3930D7BE-F8C1-4CE7-9620-53A5E6712AEA Q51302921-536E4E2F-CCB2-4C25-99CC-8A61EB472CB9

P2860

Multiallergen-specific immunotherapy in polysensitized patients: where are we?

http://www.wikidata.org/entity/Q39466603

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Multiallergen-specific immunotherapy in polysensitized patients: where are we?

@en

Multiallergen-specific immunotherapy in polysensitized patients: where are we?

@nl

type

label

Multiallergen-specific immunotherapy in polysensitized patients: where are we?

@en

Multiallergen-specific immunotherapy in polysensitized patients: where are we?

@nl

prefLabel

Multiallergen-specific immunotherapy in polysensitized patients: where are we?

@en

Multiallergen-specific immunotherapy in polysensitized patients: where are we?

@nl

P1433

Q39466603-602F667E-F4AF-4F50-A989-5C05A4489461

P1476

Q39466603-E393D6C7-9966-45FB-88DB-C99F6533280C

P2093

Q39466603-179D3E31-D71A-4A87-B81D-F83D99FE7126

Q39466603-413FBCB5-17D1-4E0F-B254-C6C71EB108BF

Q39466603-C7CC68E6-E728-421F-B53E-78D89D101EC5

P2860

Q39466603-00EB41A0-FE09-46F8-8AC9-98BBF23A97A8

Q39466603-0CB6382F-5FEE-4835-902E-C02D424EC210

Q39466603-0F13FF4D-101F-48DF-983A-C7A2EB017449

Q39466603-25AEA325-875B-4C7A-AC5A-91EB8D6738D1

Q39466603-28F6F469-0E37-434B-A456-24D712B17632

Q39466603-2C358C39-57E5-4B0B-AF49-3FAFDF44DF74

Q39466603-41D60116-6065-4FE5-8980-E9A048B3732F

Q39466603-4302A64D-782F-4669-BF5F-29BA802E8021

Q39466603-4517A0E3-F3C6-4AB1-AF92-892859243A4A

Q39466603-48C258C8-F4EF-48F9-AF74-E78CC9736F48

P304

Q39466603-D63F0B5F-1DA1-4F9A-8980-E26188942EFE

P31

Q39466603-F75F7F33-DA97-4181-A827-64FFF253E92A

P356

Q39466603-B1945CA7-8246-4A81-9616-225996B95575

P433

Q39466603-1D8B36E2-3FB1-4F18-BA60-A8B316F07EA9

P478

Q39466603-316DC962-C6B8-4A32-82A4-FC542BC59326

P577

Q39466603-A5EBA37C-0288-442C-B3B8-DF82112A56F8

P698

Q39466603-A3073115-76BD-4310-9702-D5A7A1653E39

P921

Q39466603-9345BDEE-CA0D-4C02-A1EB-2263CAE01ED1

P356

P1433

P1476

Multiallergen-specific immunotherapy in polysensitized patients: where are we?

@en

P2093

Nazan Cobanoglu

http://www.w3.org/2001/XMLSchema#string

Nerin Nadir Bahceciler

http://www.w3.org/2001/XMLSchema#string

Nilufer Galip

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term clinical efficacy of grass-pollen immunotherapy.

Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies.

Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy.

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis.

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.

Allergen immunotherapy: where is it now?

Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age.

Multiallergen immunotherapy for allergic rhinitis and asthma.

Epigenetic mechanisms of regulation of Foxp3 expression.

P304

183-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.12.161

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23413909

http://www.w3.org/2001/XMLSchema#string

P921